Invesaro

Stocks SYK Financial statements

Financial statements

STRYKER CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data STRYKER CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue11,32512,44413,60114,88414,35117,10818,44920,49822,59525,116
Cost of revenue3,8214,2644,6635,1885,2946,1406,8717,4408,1559,051
Gross profit7,5048,1808,9389,6969,05710,96811,57813,05814,44016,065
Research and development7157878629719841,2351,4541,3881,4661,623
Selling, general and administrative4,1374,5525,0995,3565,3616,4276,3867,1117,6858,651
Operating expenses5,3295,8836,4016,9836,8348,3848,7379,17010,75111,176
Operating income2,1752,2972,5372,7132,2232,5842,8413,8883,6894,889
Interest expense228247264287315337337363409607
Other non-operating income-254-234-181-151-269-303-158148212232
Pre-tax income1,9212,0632,3562,5621,9542,2812,6833,6733,4924,514
Income tax2741,043-1,1974793552873255084991,268
Net income1,6471,0203,5532,0831,5991,9942,3583,1652,9933,246
EBITDA2,9273,1563,5033,7573,2993,8564,1195,2295,1156,459
EPS, basic4.402.739.505.574.265.296.238.347.868.49
EPS, diluted4.352.689.345.484.205.216.178.257.768.40
Shares, basic (weighted)374374374374376377378380381382
Shares, diluted (weighted)379380380380380382382384386387
Dividend per share1.57

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents3,3162,5423,6164,3372,9432,9441,8442,9713,6524,011
Short-term investments88817584829189
Receivables1,9672,1982,3322,8932,7013,0223,5653,7653,9874,039
Inventory2,0302,4652,9552,9803,4943,3143,9954,8434,7745,310
Other current assets4805377477604886627878571,5931,306
Total current assets7,8617,9939,73311,0589,70710,01710,27512,51814,84714,755
Property, plant and equipment1,5691,9752,2912,5672,7522,8332,9703,2153,4483,876
Lease right-of-use assets384423419473494516519
Goodwill6,3567,1688,5639,06912,77812,91814,88015,24315,85519,291
Intangible assets3,5083,4774,1634,2275,5544,8404,8854,5934,3955,681
Other non-current assets1,1411,3018011,6712,0092,2632,4642,6732,6843,143
Total assets20,43522,19727,22930,16734,33034,63136,88439,91242,97147,844
Accounts payable4374876466758101,1291,4131,5171,6791,799
Accrued liabilities7678389179559251,0921,1491,4781,4031,595
Short-term debt2286321,37385976171,1912,0941,4091,000
Total current liabilities3,1483,4854,8074,4005,0414,5496,3037,9217,6167,794
Long-term debt6,6866,5908,48610,23113,23012,47211,85710,90112,18814,859
Lease liabilities301325310357356379348
Other non-current liabilities7648819781,6611,9851,8201,4671,9302,1842,369
Total liabilities10,88512,21715,49917,36021,24619,75420,26821,31922,33725,424
Total debt6,6866,5908,48610,23113,23012,47211,85710,90112,18814,859
Paid-in capital1,4321,4961,5591,6281,7411,8902,0342,2002,3612,597
Retained earnings8,8428,98610,76511,74812,46213,48014,76516,77118,52820,472
Other comprehensive income-761-553-631-606-1,157-531-221-416-293-687
Shareholders' equity9,5509,96611,730
Minority interests014
Total equity9,5509,98011,73012,80713,08414,87716,61618,59320,63422,420
Total liabilities and equity20,43522,19727,22930,16734,33034,63136,88439,91242,97147,844
Shares outstanding375374

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income1,6471,0203,5532,0831,5991,9942,3583,1652,9933,246
Depreciation and amortization7528599661,0441,0761,2721,2781,3411,4261,570
Stock-based compensation97113119127142171168205229243
Deferred income tax-4636-1,58212648-23758-206-370392
Change in receivables-192-162-60-563354-377-579-175-321127
Change in inventory-299-320-385-40027-189-762-797-206-297
Cash from operations1,9151,5592,6102,1913,2773,2632,6243,7114,2425,044
Capital expenditures-490-598-572-649-487-525-588-575-755-761
Acquisitions-4,332-831-2,451-802-4,222-339-2,563-390-1,628-4,960
Purchases of investments-151-270-226-74-54-49-52-52-58
Sales and maturities of investments78587394696155435449
Cash from investing-4,191-1,613-2,857-1,455-4,701-859-2,924-962-3,000-4,866
Debt issued3,4534993,1262,6423,29251,5001,2413,0112,979
Debt repaid-7500-669-1,342-2,297-1,151-653-2,058-2,039-1,400
Share buybacks-13-230-300-30700
Dividends paid-568-636-703-778-863-950-1,051-1,139-1,219-1,284
Cash from financing2,258-7941,3293-11-2,365-749-1,594-525113
Exchange rate effect-4574-8-1841-38-51-28-3668
Net change in cash-63-7741,074721-1,3941-1,1001,127681359
Free cash flow1,4259612,0381,5422,7902,7382,0363,1363,4874,283
Interest paid180231248286304325324356396582
Income taxes paid5103125394573236225056939891,002

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $272.36 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin65.0%Gross profit / revenue.
Operating margin21.4%Operating income / revenue.
EBITDA margin27.7%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin19.9%Pre-tax income / revenue.
Net margin14.4%Net income / revenue.
FCF margin18.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin21.4%Cash from operations / revenue.
Effective tax rate27.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)7.8%Net income / average total assets.
R&D / revenue6.4%Research and development expense / revenue.
SG&A / revenue34.0%Selling, general and administrative expense / revenue.
Stock-based pay / revenue1.0%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.2%Capital expenditures / revenue.
D&A / revenue6.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y11.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y10.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y11.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y11.5%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y12.1%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y32.5%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y19.8%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y17.1%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y26.3%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y16.2%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y14.4%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y8.5%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y11.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y15.2%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y8.2%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y10.8%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y14.9%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y18.9%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y24.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y9.0%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y22.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y28.1%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y9.0%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y11.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y9.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y6.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.16xCurrent assets / current liabilities.
Quick ratio1.08x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.52x(Cash + short-term investments) / current liabilities.
Debt / assets29.6%Total debt / total assets.
Liabilities / assets50.0%Total liabilities / total assets.
Net debt$10.72BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA1.50xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage9.62xOperating income / interest expense.
Working capital$7.73BCurrent assets - current liabilities.
Goodwill and intangibles / assets52.8%(Goodwill + intangible assets) / total assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.54xRevenue / average total assets.
Fixed asset turnover6.53xRevenue / average property, plant and equipment.
Inventory turnover1.64xCost of revenue / average inventory.
Days inventory223 days365 x average inventory / cost of revenue.
Receivables turnover6.90xRevenue / average receivables.
Days sales outstanding53 days365 x average receivables / revenue.
Days payables67 days365 x average accounts payable / cost of revenue.
Cash conversion cycle208 daysDays inventory + days sales outstanding - days payables.
FCF conversion126.1%Free cash flow / net income, when net income is positive.
Capex / operating cash flow14.9%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$9.65Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$66.94Revenue / diluted weighted shares.
FCF per share$12.18Free cash flow / diluted weighted shares.
Operating cash flow per share$14.31Cash from operations / diluted weighted shares.
Cash per share$9.01(Cash + short-term investments) / shares outstanding.
Payout ratio35.3%Dividends paid / net income, when net income is positive.
Dividends / FCF28.0%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$104.47BShare price x shares outstanding.
Enterprise value$115.19BMarket cap + total debt - cash - short-term investments.
P/E28.0xMarket cap / net income. Only when net income is positive.
P/S4.04xMarket cap / revenue.
P/FCF22.2xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF18.9xMarket cap / cash from operations, when positive.
EV/Sales4.46xEnterprise value / revenue.
EV/EBIT20.8xEnterprise value / operating income, when both are positive.
EV/EBITDA16.1xEnterprise value / EBITDA, when both are positive.
EV/FCF24.5xEnterprise value / free cash flow, when both are positive.
FCF yield4.5%Free cash flow / market cap.
Earnings yield3.6%Net income / market cap (the inverse of P/E).
Dividend yield1.3%Dividends paid over the period / market cap.
Shareholder yield1.3%(Dividends paid + share buybacks) / market cap.
PEG2.59xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was STRYKER CORP's revenue in fiscal 2025?

STRYKER CORP reported revenue of $25.12B for fiscal 2025, 11.2% higher than the year before.

Was STRYKER CORP profitable in fiscal 2025?

Yes. Net income was $3.25B, a net margin of 12.9%.

How much free cash flow did STRYKER CORP generate in fiscal 2025?

Cash from operations of $5.04B minus capital expenditures of $761.0M left free cash flow of $4.28B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to STRYKER CORP